Safety of TNF-alpha inhibitors during IBD pregnancy: a systematic review

Ole Haagen Nielsen; Edward V Loftus; Tine Jess

doi:10.1186/1741-7015-11-174

Safety of TNF-alpha inhibitors during IBD pregnancy: a systematic review

Ole Haagen Nielsen, Edward V Loftus, Tine Jess

Mave-, Tarm- og Leversygdomme

119 Citationer (Scopus)

Abstract

Tumor necrosis factor (TNF)-alpha inhibitors are increasingly being used in inflammatory bowel disease (IBD). Because this chronic intestinal disorder often affects women of fertile age, it is essential to assess the effect of biologics on pregnancy outcome.

Originalsprog	Engelsk
Tidsskrift	B M C Medicine
Vol/bind	11
Udgave nummer	1
Sider (fra-til)	174
ISSN	1741-7015
DOI	https://doi.org/10.1186/1741-7015-11-174
Status	Udgivet - 31 jul. 2013

Adgang til dokumentet

10.1186/1741-7015-11-174

Citationsformater

@article{2ded196166e445108c2bc4562ba94cb6,

title = "Safety of TNF-alpha inhibitors during IBD pregnancy: a systematic review",

abstract = "Tumor necrosis factor (TNF)-alpha inhibitors are increasingly being used in inflammatory bowel disease (IBD). Because this chronic intestinal disorder often affects women of fertile age, it is essential to assess the effect of biologics on pregnancy outcome.",

author = "Nielsen, {Ole Haagen} and Loftus, {Edward V} and Tine Jess",

year = "2013",

month = jul,

day = "31",

doi = "10.1186/1741-7015-11-174",

language = "English",

volume = "11",

pages = "174",

journal = "B M C Medicine",

issn = "1741-7015",

publisher = "BioMed Central Ltd",

number = "1",

}

TY - JOUR

T1 - Safety of TNF-alpha inhibitors during IBD pregnancy

T2 - a systematic review

AU - Nielsen, Ole Haagen

AU - Loftus, Edward V

AU - Jess, Tine

PY - 2013/7/31

Y1 - 2013/7/31

N2 - Tumor necrosis factor (TNF)-alpha inhibitors are increasingly being used in inflammatory bowel disease (IBD). Because this chronic intestinal disorder often affects women of fertile age, it is essential to assess the effect of biologics on pregnancy outcome.

AB - Tumor necrosis factor (TNF)-alpha inhibitors are increasingly being used in inflammatory bowel disease (IBD). Because this chronic intestinal disorder often affects women of fertile age, it is essential to assess the effect of biologics on pregnancy outcome.

U2 - 10.1186/1741-7015-11-174

DO - 10.1186/1741-7015-11-174

M3 - Journal article

C2 - 23902720

SN - 1741-7015

VL - 11

SP - 174

JO - B M C Medicine

JF - B M C Medicine

IS - 1

ER -

Safety of TNF-alpha inhibitors during IBD pregnancy: a systematic review

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater